Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,992 | 19,049 | 39,850 | 589 | 0 |
| Gross Profit | 10,992 | 19,049 | 39,850 | 589 | N/A |
| Operating Expenses | 73,066 | 29,612 | 21,624 | 23,294 | 19,968 |
| Operating Income | -62,074 | -10,563 | 18,226 | -22,705 | -19,968 |
| Interest Expense | 0 | 0 | 9 | 2 | 6,847 |
| Other Income | 4,542 | 589 | -14 | -33,986 | 2,195 |
| Pre-tax Income | -57,532 | -9,974 | 18,203 | -56,693 | -24,620 |
| Income Tax | N/A | 12 | 315 | N/A | N/A |
| Net Income Continuous | -57,532 | -9,986 | 17,888 | -56,693 | -24,620 |
| Net Income | $-57,532 | $-9,986 | $17,888 | $-56,693 | $-24,620 |
| EPS Basic Total Ops | -2.15 | -0.46 | 0.90 | -3.82 | -5.28 |
| EPS Basic Continuous Ops | -2.15 | -0.46 | 0.90 | -3.82 | -5.28 |
| EPS Diluted Total Ops | -2.15 | -0.46 | 0.87 | -3.82 | -5.28 |
| EPS Diluted Continuous Ops | -2.15 | -0.46 | 0.87 | -3.82 | -5.28 |
| EPS Diluted Before Non-Recurring Items | -2.15 | -0.46 | 0.87 | -0.72 | -5.28 |
| EBITDA(a) | $-62,064 | $-10,557 | $18,230 | $-22,701 | $-19,960 |